Vanguard Group’s Indaptus Therapeutics INDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,152
| Closed | -$141K | – | 4304 |
|
|
2025
Q1 | $141K | Hold |
9,152
| – | – | ﹤0.01% | 4102 |
|
|
2024
Q4 | $216K | Hold |
9,152
| – | – | ﹤0.01% | 4095 |
|
|
2024
Q3 | $318K | Hold |
9,152
| – | – | ﹤0.01% | 4067 |
|
|
2024
Q2 | $543K | Hold |
9,152
| – | – | ﹤0.01% | 3979 |
|
|
2024
Q1 | $574K | Hold |
9,152
| – | – | ﹤0.01% | 3981 |
|
|
2023
Q4 | $451K | Buy |
9,152
+197
| +2% | +$12.4K | ﹤0.01% | 4072 |
|
|
2023
Q3 | $691K | Buy |
8,955
+14
| +0.2% | +$946 | ﹤0.01% | 3958 |
|
|
2023
Q2 | $478K | Hold |
8,941
| – | – | ﹤0.01% | 4131 |
|
|
2023
Q1 | $463K | Hold |
8,941
| – | – | ﹤0.01% | 4141 |
|
|
2022
Q4 | $363K | Buy |
8,941
+4
| +0% | +$202 | ﹤0.01% | 4183 |
|
|
2022
Q3 | $541K | Buy |
8,937
+117
| +1% | +$9.11K | ﹤0.01% | 4190 |
|
|
2022
Q2 | $645K | Buy |
8,820
+169
| +2% | +$13.2K | ﹤0.01% | 4219 |
|
|
2022
Q1 | $969K | Buy |
8,651
+1,365
| +19% | +$175K | ﹤0.01% | 4218 |
|
|
2021
Q4 | $1.16M | Buy |
7,286
+4,577
| +169% | +$850K | ﹤0.01% | 4223 |
|
|
2021
Q3 | $594K | Buy |
+2,709
| New | +$782K | ﹤0.01% | 4357 |
|
Other funds holding INDP
SS
TRCT
